Table 3 Prevalence of CVD risk factors and accessibility to CVD risk screening across age groups
A. CVD risk factors | Age group in years (95% confidence interval) | p-values | ||||||
|---|---|---|---|---|---|---|---|---|
18-24 | 25-34 | 35-44 | 45-54 | 55-64 | 65-74 | ≥75 | ||
↑TG | 10.2 (5.1-15.6) | 11.4 (2.9-20.0) | 22.4 (10.2-32.7) | 32.3 (21.0-43.5) | 46.9 (28.1-63.8) | 37.5 (16.2-62.5) | 48.4 (29.0-67.7) | <0.0001 |
↑CHOL | 23.4 (16.1-30.7) | 22.9 (11.4-35.5) | 32.7 (21.6-46.9) | 48.4 (33.9-61.3) | 59.4 (40.6-75.0) | 62.5 (37.5-81.3) | 74.2 (56.7-90.3) | <0.0001 |
Obesity (BMI) | 2.2 (0.0-4.4) | 17.1 (5.7-28.6) | 16.3 (6.1-28.6) | 32.3 (21.0-43.5) | 15.6 (6.3-28.1) | 12.5 (0.0-31.3) | 12.9 (3.2-25.8) | <0.0001 |
↓HDL | 19.7 (13.1-27.0) | 34.3 (20.0-51.4) | 20.4 (10.2-34.7) | 14.5 (6.5-24.2) | 12.5 (3.1-25.0) | 6.3 (0.0-25.0) | 6.5 (0.0-17.5) | 0.053 |
Prediabetes | 3.6 (0.7-7.3) | 2.9 (0.0-11.4) | 8.2 (2.0-16.3) | 6.5 (1.6-12.9) | 0.0 | 0.0 | 6.5 (0.0-16.1) | 0.398 |
Diabetes | 0.7 (0.0-2.9) | 0.0 | 4.1 (0.0-10.2) | 8.1 (1.6-14.5) | 18.8 (6.3-31.3) | 25.0 (6.3-50.0) | 6.5 (0.0-16.1) | <0.0001 |
Hypertension | 7.3 (2.9-11.7) | 28.6 (14.3-42.9) | 40.8 (26.5-55.1) | 54.8 (38.7-66.1) | 68.8 (50.0-84.4) | 56.3 (37.5-81.3) | 71.0 (54.8-85.2) | <0.0001 |
Obesity (WC) | 16.8 (10.2-22.6) | 51.4 (34.3-68.6) | 77.6 (64.5-88.6) | 79.0 (67.7-88.7) | 87.5 (75.0-96.9) | 68.8 (43.8-87.5) | 64.5 (48.4-80.6) | <0.0001 |
B. CVD risk screening | Â | Â | ||||||
Have had BP measured | 6.7 (3.4-11.4) | 43.6 (28.2-61.5) | 70.5 (59.0-82.0) | 86.4 (78.8-93.9) | 83.3 (69.4-94.4) | 65.0 (45.0-85.0) | 51.2 (36.6-65.9) | <0.0001 |
Have had BG measured | 3.4 (0.7-6.7) | 7.7 (0.0-15.4) | 26.2 (14.8-37.7) | 36.4 (24.2-47.0) | 55.6 (38.9-69.4) | 35.0 (15.0-55.0) | 19.5 (7.3-31.7) | <0.0001 |
Have had CHOL measured | 1.3 (0.0-3.4) | 0.0 | 4.9 (0.0-11.5) | 4.5 (0.0-10.6) | 11.1 (2.8-22.2) | 5.0 (0.0-15.0) | 7.3 (0.0-17.1) | 0.094 |